Cytotoxicity and antitumor activity of 2',2'-difluorodeoxycytidine (Gemcitabine).
Grindey
G B
GB
Lilly Research Laboratories, Indianapolis, Indiana 46285.
Hertel
L W
LW
Plunkett
W
W
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D051379:Mice; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine